Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Capital Expenditures (2019 - 2025)

Historic Capital Expenditures for SRx Health Solutions (SRXH) over the last 7 years, with Q1 2025 value amounting to $7000.0.

  • SRx Health Solutions' Capital Expenditures rose 13333.33% to $7000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $3.5 million, marking a year-over-year increase of 3185454.55%. This contributed to the annual value of $18000.0 for FY2023, which is 9090.91% down from last year.
  • Latest data reveals that SRx Health Solutions reported Capital Expenditures of $7000.0 as of Q1 2025, which was up 13333.33% from $11000.0 recorded in Q3 2024.
  • In the past 5 years, SRx Health Solutions' Capital Expenditures registered a high of $3.5 million during Q2 2024, and its lowest value of $3000.0 during Q1 2024.
  • In the last 5 years, SRx Health Solutions' Capital Expenditures had a median value of $25000.0 in 2022 and averaged $340333.3.
  • As far as peak fluctuations go, SRx Health Solutions' Capital Expenditures skyrocketed by 280000.0% in 2021, and later plummeted by 9333.33% in 2023.
  • Quarter analysis of 5 years shows SRx Health Solutions' Capital Expenditures stood at $229000.0 in 2021, then tumbled by 96.07% to $9000.0 in 2022, then dropped by 11.11% to $8000.0 in 2023, then surged by 37.5% to $11000.0 in 2024, then plummeted by 36.36% to $7000.0 in 2025.
  • Its Capital Expenditures stands at $7000.0 for Q1 2025, versus $11000.0 for Q3 2024 and $3.5 million for Q2 2024.